|
Zelnorm (tegaserod maleate)
Information
FDA approved a new label for zelnorm. The major changes to the
Zelnorm label include a new warning about serious consequences of
diarrhea, a new precaution about ischemic colitis and other forms of
intestinal ischemia, and updated labeling for patients that includes
information about these potential side effects and advises that
patients should stop taking Zelnorm and contact their doctor.
Zelnorm is used for the short-term treatment of women with irritable
bowel syndrome (IBS) whose primary bowel symptom is constipation.
Back to Drug Info
Date created: April 28, 2004 |
